¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"specific heart muscle disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® heart disease ÇÑ±Û ½ÉÀ庴
¼³¸í   
  ¼øÈ¯±â Áúȯ Áß ½ÉÀåÀÇ º´. ÀϹÝÀûÀ¸·Î ½ÉÀåÇ÷°üÀ̳ª ½ÉÀåÀÇ º´µµ Æ÷ÇԵȴÙ. º´ÅÍÀÇ ºÎÀ§¿¡ ÀÇÇÑ º´¸®ÇغÎÇÐÀû ºÐ·ù¿Í º´Àο¡ ÀÇÇÑ ºÐ·ù°¡ ÀÖ´Ù. ÀüÀڴ ¼ö ½Ê ³â ÀüºÎÅÍ ¾²¿©Á® ¿ÔÀ¸³ª ±Ù³â¿¡ ¿Í¼­ º»ÁúÀûÀΠ¿øÀοä¹ýÀÌ °¡´ÉÇϰԠµÈ ÀÌÈĴ ÈÄÀÚÀÇ ºÐ·ù°¡ ÀÇÀǰ¡ À־ ¸¹ÀÌ ¾²À̰ԠµÇ¾ú´Ù. º´ÅÍ ºÎÀ§·Î´Â ½É³»¸·(ÆÇ¸·)-½ÉÀå±Ù-½ÉÀ帷, ±× ¹ÛÀÇ °ÍÀ» µé ¼ö ÀÖÀ¸¸ç, °¢°¢ ½É³»¸·¿°-½ÉÀåÆÇ¸·Áõ-½É±Ù¿°-½É±Ù°æ»ö-½ÉÀ帷¿°-¼±Ãµ¼º ½ÉÀ庴(½ÉÀå±âÇü) µîÀÌÆ÷ÇԵȴÙ. º´Àκ°¿¡¼­´Â ½ÉÀå±âÇüÀ» ºñ·ÔÇÏ¿© ·ù¸¶Ä¡½º ½ÉÀ庴-¸Åµ¶¼º ½ÉÀ庴-°íÇ÷¾Ð¼º ½ÉÀ庴-½ÉÀ嵿¸Æ°æÈ­¼º ½ÉÀ庴-Æó¼º½ÉÀå-¼¼±Õ¼º ½É³»¸·¿°-½ÉÀå½Å°æÁõ µîÀ¸·Î ³ª´©¾îÁö¸ç, ºÎÁ¤¸ÆÀ̳ª ¹æ½ÇÂ÷´Ü µîÀÇ ÀÚ±ØÀüµµ°èÀÇ Àå¾Ö¿¡ ÀÇÇÑ °Íµµ Áõ¼¼ÀÇ Çϳª·Î º¼ ¼ö ÀÖ´Ù. ½ÉÀ庴Àº ÀÚ°¢ÀûÀ¸·Î´Â ¹«Áõ¼¼ÀΠ°Í¿¡¼­ºÎÅÍ ½ÉÀå±â´É»ó½Ç·Î È£Èí°ï¶õ±îÁö ÀÖ´Ù.
¿µ¹® striated muscle ÇÑ±Û °¡·Î¹«´Ì±Ù
¼³¸í   
  Ç¥¸é¿¡ °¡·ÎÁÙ¹«´Ì°¡ º¸À̴ ±ÙÀ°. ¶æ´ë·Î ¿òÁ÷ÀÏ ¼ö ÀÖÀ¸¹Ç·Î ¼öÀDZÙÀ̶ó°íµµ ºÒ¸°´Ù. ÀÎüÀÇ °¡·Î¹«´Ì±ÙÀÇ ´ëºÎºÐÀº °ñ°Ý±ÙÀ̸ç, ¾ó±¼ÀÇ ÇǺθ¦ ¿òÁ÷À̴ ǥÁ¤±Ù, Çô³ª Èĵθ¦ ¿òÁ÷À̴ ±ÙÀ°µµ °¡·Î¹«´Ì±ÙÀÌ´Ù. ¿¹¸¦ µé¾î ÆÈÀ» ±¸ºÎ¸± ¶§´Â ¸¹Àº ±ÙÀ°ÀÇ º¹ÀâÇÑ ÇùÁ¶°¡ ÇÊ¿äÇÏ¿© ÀüüÀûÀΠ¿òÁ÷ÀÓÀ» ÅëÁ¦Çϴ ±â±¸°¡ ÀÖ´Ù. ¶Ç ÀÚ¼¼ÀÇ ±ÕÇüÀ» ÀâÀ» ¶§ µî ¸¹Àº ¿îµ¿À» ¹«ÀǽÄÀû-¹Ý»çÀûÀ¸·Î Á¶ÀýÇϴ ±â±¸µµ ÀÖ´Ù. ½ÉÀå±ÙÀº °¡·Î¹«´Ì±ÙÀÌÁö¸¸ ºÒ¼öÀDZÙÀÇ ¼ºÁúÀ» °¡Á³´Ù.
¿µ¹® skeletal muscle ÇÑ±Û °ñ°Ý±Ù
¼³¸í   
  °ñ°Ý¿¡ ºÙ¾î ±× ¿îµ¿À» °üÀåÇϴ ±ÙÀ°°è. °ñ°Ý±Ù-ÆòȰ±Ù-½ÉÀå±Ù µî ¼¼ °³ ±ÙÁ¶Á÷ÀÇ Çϳª. ±½±â 10~100¥ì, ±æÀÌ 5~12cmÀÇ °¡´Ã°í ±ä ±ÙÀ°¼¶À¯ÀÇ ÁýÇÕüÀ̸ç, °¡·Î¹«´Ì°¡ ÀÖ°í, ¼öÀǿÀ» ÇÑ´Ù. ÇÑ °³ÀÇ °ñ°Ý±ÙÀº ´Ù¼öÀÇ ±Ù¼¶À¯¿Í °áÇÕÁ¶Á÷À¸·Î ±¸¼ºµÇ°í °¢±â Æ¯À¯ÇÑ ÇüŸ¦ Áö´Ñ´Ù. ±ÙÀ°ÀÇ ¾ç³¡Àº °¡´Ã¸ç ±× ºÎºÐÀ» ±ÙÀ°¸Ó¸®¶ó°í ÇÑ´Ù. ±ÙÀ°¸Ó¸®´Â ÈûÁٷΠÀÌÇàÇϸç ÈûÁÙÀº »À¸·¿¡ ºÙ´Âµ¥, ¶§·Î´Â »À¸·À» Œä°í »À¿¡ ºÎÂøµÇ¾î ÀÖ´Ù. ±ÙÀ°ÀÇ Á߾Ӻδ ±½°í µÎ²¨¿ì¸ç À̺κÐÀ» ±Ùº¹À̶ó ÇÑ´Ù. ±ÙÀ°¸Ó¸®´Â ´Ù½Ã µÎ°¥·¡±Ù-¼¼°¥·¡±Ù-³×°¥·¡±ÙÀ¸·Î ³ª´¶´Ù. ±ÙÀ°ÀÇ ¿îµ¿ ÀÚü´Â Ç×»ó ±Ù¼¶À¯ÀÇ ¹æÇâ¿¡ µû¸£´Â ¼öÃà¿îµ¿»ÓÀÌ´Ù. ±×·¯³ª °ñ°Ý±ÙÀÌ »À¿¡ ºÙÀº À§Ä¡¿¡ µû¶ó »À´ë¿¡ ´ëÇÑ ¿©·¯ °¡Áö ¿îµ¿À» ÇϰԠµÈ´Ù. ¿îµ¿Çϴ ÇüÅ·Π°ñ°Ý±ÙÀ» ºÐ·ùÇÏ¸é Æï±Ù-±ÁÈû±Ù-³»Àü±Ù-¿ÜÀü±Ù-ȸ¿Ü±Ù-ȸ³»±Ù-¿Ã¸²±Ù µîÀÌ ÀÖ´Ù. ±ÁÈ÷°í Æï-³»¿ÜÀü-ȸ³»¿ÜÀÇ ¿îµ¿Àº °üÀýÃàÀ» Áß½ÉÀ¸·Î ÇàÇÑ´Ù. °°Àº °ñ°Ý¿¡ ´ëÇÏ¿© Æß±ÙÀ°°ú ±ÁÈû±ÙÀ°ÀÌ °¢±â ¹Ý´ë¿îµ¿À» ÇÒ °æ¿ì¿¡´Â ¾ç ±ÙÀ°À» ¼­·Î ´ëÇ×±ÙÀ̶ó Çϰí, °øµ¿¿îµ¿À» Çϴ °æ¿ì¿¡´Â °øµ¿±ÙÀ̶ó ÇÑ´Ù. 
¿µ¹® muscle ÇÑ±Û ±ÙÀ°
¼³¸í   
  ÀǽÄÀÇ Á¶Àý¿©ºÎ¿¡ µû¶ó ¼öÀDZÙ(ÀǽĿ¡ ÀÇÇØ¼­ Á¶ÀýÀÌ °¡´ÉÇÑ ±ÙÀ°: ¿¹¸¦ µé¾î ´Ù¸®, ÆÈ, ¾ó±¼±ÙÀ° µî)°ú ºÒ¼öÀDZÙ(Àǽİú ¹«°üÇϰԠÁ¶ÀýÇÏÁö ¾Ê¾Æµµ ¿òÁ÷À̴ ±ÙÀ°: ¿¹¸¦ µé¾î ½ÉÀå±Ù, ¼ÒÈ­±â°ü¿¡ ºÐÆ÷Çϴ ±ÙÀ° µî)À¸·Î ³ª´©¾îÁú ¼ö ÀÖÀ¸¸ç, ¶ÇÇÑ ½ÉÀå±ÙÀÌ µû·Î Á¸ÀçÇÑ´Ù.
¿µ¹® muscle biopsy ÇÑ±Û ±ÙÀ°»ý°Ë
¼³¸í   
  »ýü³»¿¡¼­ ±ÙÀ°¿¡ ´ëÇÑ Áúº´ÀÇ °¨º°Áø´ÜÀ» À§Çؼ­ ½Ç½ÃÇϴ °Ë»ç¹ý. ¹æ¹ýÀº º´ÅͰ¡ Àִ ºÎÀ§³ª È¤Àº ¾ø¾îµµ Å©°Ô È°µ¿¿¡ ÁöÀåÀÌ ¾ø´Â ±ÙÀ°ºÎÀ§ÀÇ Á¶Á÷À» ¶¼¾î Çö¹Ì°æÀûÀ¸·Î °Ë»çÇÑ´Ù. ¿¹¸¦ µé¾î ½Å°æÁ¶Á÷ÀÇ ÀÌ»óÀ¸·Î ÀÎÇÑ ±ÙÀ°º´ÅÍÀÇ °æ¿ì, ±ÙÀ°»ý°ËÀ» ÇÏ¿© °üÂûÇØº¸¸é À̸¥¹Ù ¡°¹«¸®Áø À§Ãà(grouped atrophy)¡±ÀÌ ³ªÅ¸³ª¼­, ´Ù¸¥ º´ÅÍ¿¡ ÀÇÇÑ °Í°ú °¨º°ÀÌ °¡´ÉÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • granulocyte-specific antigen
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • group-specific
    ±ºÆ¯ÀÌ-
  • group-specific antigen
    ¹«¸®Æ¯ÀÌÇ׿ø, ±ºÆ¯ÀÌÇ׿ø
  • neuron-specific enolase
    ´º·±Æ¯ÀÌ¿¡³î¶ó¾ÆÁ¦
  • organ specific antigen
    Àå±âƯÀÌÇ׿ø
  • platelet-specific antigen
    Ç÷¼ÒÆÇƯÀÌÇ׿ø
  • prostate specific antigen
    Àü¸³»ùƯÀÌÇ׿ø
  • species-specific
    Á¾Æ¯ÀÌ-
  • species-specific antigen
    Á¾Æ¯ÀÌÇ׿ø
  • species-specific reactivity
    Á¾Æ¯À̹ÝÀÀ¼º
  • specific
    1. ƯÀÌ-, ƯÁ¤- 2. Á¾-
  • specific absorption rate
    ºñÈí¼öÀ²
  • specific action
    ƯÀÌÀÛ¿ë
  • specific activity
    1. ºñ¹æ»ç´É 2. ºñ(Ýï)Ȱ¼ºµµ, °íÀ¯È°¼ºµµ
  • specific antagonist
    ƯÀÌ´ëÇ×Á¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • smooth muscle fiber
    ¹Î¹«´Ì±ÙÀ°¼¶À¯, ¹Î¹«´Ì±ÙÀ°¼¼Æ÷
  • white muscle fiber
    ¹é»ö±ÙÀ°¼¶À¯, ¹é»ö±ÙÀ°¼¼Æ÷
  • muscle
    ±ÙÀ°
  • abdominal muscle
    ¹è±ÙÀ°, º¹±Ù
  • facial muscle
    ¾ó±¼±ÙÀ°
  • gastrocnemius muscle
    ÀåµýÁö±Ù
  • gluteus muscle
    º¼±â±Ù, µÐ±Ù
  • hamstring muscle
    µÚ³Ò´Ù¸®±Ù
  • iliopsoas muscle
    ¾ûµ¢Ç㸮±Ù
  • involuntary muscle
    ºÒ¼öÀDZÙ, Á¦´ë·Î±Ù
  • levator ani muscle
    Ç×¹®¿Ã¸²±Ù
  • orbicularis oculi muscle
    ´«µÑ·¹±Ù
  • pectoralis major muscle
    Å«°¡½¿±Ù, ´ëÈä±Ù
  • pterygoid muscle
    ³¯°³±Ù
  • quadriceps femoris muscle
    ³Ò´Ù¸®³×°¥·¡±Ù, ´ëÅð»çµÎ±Ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • age-specific fertility rate
    ¿¬·Éº°Ãâ»êÀ²
  • granulocyte-specific antigen
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • group-specific antigen
    ±ºÆ¯ÀÌÇ׿ø
  • organ specific antigen
    Àå±âƯÀÌÇ׿ø
  • platelet-specific antigen
    Ç÷¼ÒÆÇƯÀÌÇ׿ø
  • specific action
    ƯÀÌÀÛ¿ë
  • specific activity
    ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
  • specific antagonist
    ƯÀÌ´ëÇ×Á¦
  • specific antigen
    ƯÀÌÇ׿ø
  • specific pathogen free animal
    ƯÁ¤¹«º´¿øÃ¼µ¿¹°
  • type specific antigen
    ÇüƯÀÌÇ׿ø
  • blood group specific substance
    Ç÷¾×ÇüƯÀ̹°Áú
  • cause-specific rate
    ¿øÀκ°Æ¯¼öÀ²
  • specific charge
    °ßÁÜÀüÇÏ, ºñÀüÇÏ
  • specific compliance
    ƯÀÌź¼º, ƯÀÌÀ¯¼øµµ, ƯÀÌÀÀ¶ô
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • rectus femoris muscle ; muscle rectus femoris
    ´ëÅðÁ÷±Ù(ÓÞ!!òÁÐÉ).
  • SDA= specific dynamic action
    ƯÀ̵¿Àû ÀÛ¿ë.
  • age specific death rate
    ¿¬·Éº° »ç¸Á·ü
  • antigen, species-specific
    Á¾Æ¯ÀÌÇ׿ø
  • antigen, tumor-specific
    Á¾¾çƯÀÌÇ׿ø
  • antigen, tumor-specific transplantation
    Á¾¾çƯÀÌ À̽ÄÇ׿ø
  • antigen,tumor-specific transplantation
    Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
  • granulocyte-specific antigens
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • group specific C carbohydrate
    ±ºÆ¯ÀÌ C´Ù´çü.
  • group-specific
    ±ºÆ¯ÀÌÀÇ
  • group-specific C carbohydrate
    ±ºÆ¯ÀÌ C ź¼öÈ­¹°
  • group-specific antigen
    ±ºÆ¯ÀÌÇ׿ø
  • group-specific antigen
    ±º-ƯÀÌÇ׿ø
  • idiotype specific regulatory cell
    °³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
  • immunity, specific
    ƯÀ̸鿪
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • congenital heart disease
    ¼±Ãµ¼º ½ÉÁúȯ(à»ô¸àõãýòðü´).
  • congenital heart disease
    ¼±Ãµ¼º ½ÉÁúȯ(¡­ãýòðü´)
  • constrictive heart disease
    ±³Âø¼º ½ÉÁúȯ(¡­àõãýòðü´).
  • coronary heart disease
    °ü(»ó)µ¿¸Æ½ÉÁúȯ(ήßÒÔÑØæãýòðü´).
  • coronary heart disease
    ½ÉÀ嵿¸Æ¼º ½ÉÁúȯ(ãýíôÔÑØæàõ ãýòðü´)
  • degenerative heart disease
    ÅðÇ༺ ½ÉÁúȯ.
  • heart disease
    ½ÉÁúȯ(ãýòðü´), ½ÉÀ庴(ãýíôÜ»).
  • heart water disease
    ½É¼öº´(ãýâ©Ü»).
  • hypertensive heart disease
    °íÇ÷¾Ð¼º ½ÉÁúȯ(¡­ãýòðü´)
  • hypertensive heart disease =HHD
    °íÇ÷¾Ð¼º ½ÉÀåÁúȯ.
  • hypertensive heart disease =HHD
    °íÇ÷¾Ð¼º ½ÉÁúȯ.
  • intractable heart disease
    ³­Ä¡¼º ½ÉÀ庴.
  • ischemic heart disease
    ÇãÇ÷¼º ½ÉÁúȯ
  • ischemic heart disease
    ÇãÇ÷¼º ½ÉÁúȯ(¡­ãýòðü´)
  • ischemic heart disease =IHD
    ÇãÇ÷¼º ½ÉÁúȯ(¡­ãýòðü´).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Incisura helicis muscle
    (±ÍµÑ·¹ÆÐÀÓ±Ù)
    [¿¾ ¿ë¾î] ÀÌ·ûÀýÈç±Ù
  • Salpingopharyngeal muscle
    (±ÍÀεÎ)°üÀεαÙ
    [¿¾ ¿ë¾î] À̰üÀεαÙ
  • Striated muscle cell
    °¡·Î¹«´Ì±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] Ⱦ¹®±Ù¼¼Æ÷
  • Histogenesis of striated muscle
    °¡·Î¹«´Ì±ÙÀ°Á¶Á÷¹ß»ý
    [¿¾ ¿ë¾î] Ⱦ¹®±ÙÁ¶Á÷¹ß»ý
  • Pleuroesophageal muscle
    °¡½¿¸·½Äµµ±Ù
    [¿¾ ¿ë¾î] È丷½Äµµ±Ù
  • Lateral rectus muscle
    °¡ÂʰðÀº±Ù
    [¿¾ ¿ë¾î] ¿ÜÃøÁ÷±Ù
  • Tensor tympani muscle
    °í¸·±äÀå±Ù
    [¿¾ ¿ë¾î] °í¸·Àå±Ù
  • Semicanal for tensor tympani muscle
    °í¸·±äÀå±Ù¹Ý°ü
    [¿¾ ¿ë¾î] °í¸·Àå±Ù¹Ý°ü
  • Cremaster muscle
    °íȯ¿Ã¸²±Ù
    [¿¾ ¿ë¾î] °íȯ°Å±Ù
  • Rectovesical muscle
    °ðâÀڹ汤±Ù
    [¿¾ ¿ë¾î] Á÷À广±¤±Ù
  • Rectourethral muscle
    °ðâÀÚ¿äµµ±Ù
    [¿¾ ¿ë¾î] Á÷Àå¿äµµ±Ù
  • Ischiocavernus muscle
    ±ÃµÕÇØ¸éü±Ù
    [¿¾ ¿ë¾î] Á°ñÇØ¸éü±Ù
  • Tragicus muscle
    ±Í±¸½½±Ù
    [¿¾ ¿ë¾î] ÀÌÁÖ±Ù
  • Transversus auricularis muscle
    ±Ó¹ÙÄû°¡·Î±Ù
    [¿¾ ¿ë¾î] À̰³È¾±Ù
  • Obliquus auricularis muscle
    ±Ó¹ÙÄûºø±Ù
    [¿¾ ¿ë¾î] À̰³»ç±Ù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • specific acid-base catalysis
    ƯÀÌ »ê.¿°±â Ã˸Å(÷åì¶ß«ç¤ÐñõºØÚ)
  • specific activity
    ºñȰ¼º(ÝïüÀàõ)
  • specific adsorption
    ¼±ÅÃÈíÂø(àÔ÷Éýåó·)
  • specific dynamic action
    ƯÀÌ µ¿Àû ÀÛ¿ë(÷åì¶ÔÑîÜíÂéÄ)
  • specific extinction coefficient
    ºñÈí±¤ °è¼ö(ÝïýåÎÃÌõâ¦)
  • specific gravity
    ºñÁß(Ýïñì)
  • specific growth rate
    ºñ¼ºÀåÀ²(Ýïà÷íþëÒ)
  • specific heat
    ºñ¿­(Ýïæð)
  • specific immune suppression
    ƯÀÌ ¸é¿ª¾ï¾Ð(÷åì¶Øóæ¹åääâ)
  • specific immunity
    ƯÀ̸鿪(÷åì¶Øóæ¹)
  • specific interaction theory
    ƯÀÌ »óÈ£ÀÛ¿ëÀÌ·Ð(÷åì¶ßÓû»íÂéÄ×âÖå)
  • specific ionization
    ºñ(Ýï) ÀÌ¿ÂÈ­(ûù)
  • specific radioactivity
    ºñ¹æ»ç´É(ÝïÛ¯ÞÒÒö)
  • specific rate constant
    ƯÀÌ ¼Óµµ»ó¼ö(÷åì¶áÜÓøßÈâ¦)
  • specific reaction rate
    ƯÀÌ ¹ÝÀÀ¼Óµµ(÷åì¶ÚãëëáÜÓø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heart catheterization
    ½ÉÀåÄ«Å×Å׸£¹ý
  • heart failure
    ½ÉºÎÀü
  • heart lung machine
    ½ÉÆó±â, Àΰø½ÉÆóÀåÄ¡±â
  • heart lung ratio
    ½ÉÆó°è¼ö
  • heart scan
    ½ÉÁÖ»ç
  • heart shadow
    ½ÉÀåÀ½¿µ
  • high output heart failure
    °í¹ÚÃ⼺½ÉºÎÀü
  • hypoplastic left heart syndrome
    Á½ɽÇÇü¼ººÎÀüÁõÈıº
  • sabot heart
    ¸ñÈ­½É
  • unilocular heart
    Àϰ­½É
  • Addison's disease
    ¾Öµð½¼º´
  • air space disease
    °ø°£Áúȯ
  • caisson disease
    ÀáÇÔº´
  • celiac disease
    ¼Ò¾Æ¸¸¼º¼ÒÈ­Àå¾ÖÁõ, ¼Ò¾ÆÁö¹æº¯Áõ, º¹ºÎÁúº´
  • cerebral vascular disease
    ³úÇ÷°üÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
MD Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major...
AD accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade...
PD Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p...
RD radial deviation; radiology department; rate difference; Raynaud disease; reaction of degeneration; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IHD Ischaemic Heart Disease
KIHD Kuopi ischaemic Heart Disease Risk Factor Study
R.H.D. Rheumatic Heart Disease
VHD Valvular heart disease
CIHD chronic ischaemic heart disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • non-specific response
    ºñƯÀ̼º ¹ÝÀÀ
  • specific
    ƯÀÌÇÑ, Á¾ÀÇ, Á¾Á·ÀÇ, ƯÀÌÀÇ, ƯÀ̼ºÀÇ, ƯÀÌÀûÀÎ
    1. ÇÑ Á¾·ùÀÇ ¹Ì»ý¹°¿¡ ÀÇÇØ¼­ »ê»ýµÇ´Â. 2. Ư¼ö¼ºÀÇ. Àû¿ë, È¿°ú µîÀÌ Æ¯Á¤ÇÑ ±¸Á¶, ±â´É µî¿¡ ÇÑÁ¤µÈ. 3. ƯȿÀÇ ¾î¶² ƯÁ¤ Áúȯ¿¡ ´ëÇØ¼­ Ưº°È÷ À¯È¿ÇÑ ÀǾàǰ. 4. ¸é¿ªÇп¡ À־ ´ëÀÀÇÏ´Â Ç×ü¿¡ ´ëÇÑ Ç׿øÀÇ Æ¯º°ÇÑ Ä£È­¼º¿¡ °üÇÑ.
  • specific activity
    ƯÀÌ È°¼º, ƯÀÌ È°¼ºµµ, ºñȰ¼º, ºñȰ¼ºµµ
  • specific alopecia
    Ư¼ö Å»¸ðÁõ
  • specific criteria
    ƯÀÌÇÑ ±âÁØ
  • specific dentist-patient relationship
    µ¶Æ¯ÇÑ Ä¡°ú ÀÇ»ç-ȯÀÚ °ü°è
  • specific energy of sense
    Ư¼ö °¨°¢ ¿¡³ÊÁö
  • specific gamma emission
    Ư¼ö °¨¸¶ ¹æÃâ
  • specific gravity test
    ºñÁß ½ÃÇè
  • specific humoral immunity
    ƯÀ̼º ü¾× ¸é¿ª
  • specific inflammation
    ƯÀ̼º ¿°Áõ
  • specific membrane receptor
    ƯÁ¤ ¸· ¼ö¿ë±â
  • specific opiate receptor site
    Ưº°ÇÑ ¾ÆÆí ¼ö¿ëºÎ
  • specific receptor
    ƯÀÌ ¼ö¿ëü, ƯÀÌ ¼ö¿ë±â
  • specific region
    ƯÀÌ ºÎÀ§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
muscle, central core disease of One of the conditions that produces 'floppy baby' syndrome. Ccd causes hypotonia (inadequately toned muscles characterised by floppiness) in the newborn baby, slowly progressive muscle weakness, and muscle cramps after exercise. Muscle biopsy shows a key diagnostic finding (absent mitochondria in the centre of many type i muscle fibres). Ccd is inherited as a dominant trait. The ccd gene is on chromosome 19 (and involves ryanodine receptor-1).
(12 Dec 1998)
disease, central core, of muscle <anatomy> One of the conditions that produces 'floppy baby' syndrome. CCD causes hypotonia (floppiness) in the newborn baby, slowly progressive muscle weakness, and muscle cramps after exercise. Muscle biopsy shows a key diagnostic finding (absent mitochondria in the centre of many type I muscle fibres). CCD is inherited as a dominant trait. The CCD gene is on chromosome 19 (and involves ryanodine receptor-1).
(12 Dec 1998)
extra-ocular muscle disease <radiology> Graves disease, pseudotumour, lymphoma, metastasis, infection, carotid-cavernous fistula, granulomatous disease
(12 Dec 1998)
age-specific rate A rate for a specified age group, in which the numerator and denominator refer to the same age group.
(05 Mar 2000)
Bensley's specific granules Granule's in the cells of the islands of Langerhans in the pancreas.
(05 Mar 2000)
brain-specific kinase <enzyme> Expressed specifically in brain; member of the eph/elk receptor-like kinase family; mw 105 kD; may represent murine homolog of chicken cek7 receptor-like kinase; amino acid sequence given in first source
Registry number: EC 2.7.1.-
Synonym: bsk tyrosine kinase
(26 Jun 1999)
galactosyl-1-3-N-acetylgalactosaminyl-specific 2,6-sialyltransferase <enzyme> Genbank x77775
Registry number: EC 2.4.99.-
Synonym: galbeta1,3galnac 2,6-sialyltransferase, st6galnac II
(26 Jun 1999)
glycoprotein hormone-specific N-acetylgalactosamine transferase <enzyme> Transfers galnac to the terminal glcnac moieties of glcnac2man3glcnac2asn
Registry number: EC 2.4.1.-
Synonym: ghs-acgalnh2 transferase, glycoprotein hormone galnac transferase, glycoprotein hormone - n-acetylgalactosaminyltransferase
(26 Jun 1999)
retina-specific amine oxidase <enzyme> Genbank d88213
Registry number: EC 1.4.-
Synonym: rao enzyme, human
(26 Jun 1999)
Gomori's non-specific acid phosphatase stain <technique> A method in which formalin-fixed frozen sections are incubated in a substrate containing sodium beta-glycerophosphate and lead nitrate at pH 5.0; the insoluble lead phosphate produced is treated with ammonium sulfide to give a black lead sulfide.
(05 Mar 2000)
Gomori's non-specific alkaline phosphatase stain <technique> A calcium-cobalt sulfide method using frozen sections or cold acetone-or formalin-fixed paraffin sections, plus sodium beta-glycerophosphate as a substrate at pH 9.0 to 9.5 with Mg++ as activator; calcium ions precipitate the liberated phosphate, cobalt salt replaces the calcium phosphate, and ammonium sulfide converts the product to a black cobalt sulfide.
(05 Mar 2000)
group-specific protease <enzyme> A serine protease, obtained from rat small intestine, which preferentially inactivates the apo forms of certain pyridoxal phosphate requiring enzymes
Registry number: EC 3.4.21.-
(26 Jun 1999)
RNA, transfer, amino acid-specific A group of transfer rnas which are specific for carrying each one of the 20 amino acids to the ribosome in preparation for protein synthesis.
(12 Dec 1998)
poly A specific exoribonuclease <enzyme> Acts on 2' or 3'-linked oligoriboadenylates to liberate 5'-AMP
Registry number: EC 3.1.13.-
Synonym: 2',3'-exoribonuclease, 3'-exoribonuclease
(26 Jun 1999)
poly(A)-specific ribonuclease <enzyme> From vigna unguiculata seedlings; bifunctional enzyme responsible for both poly(a)-polymerizing and poly(a)-hydrolyzing activities; removes the poly(a) tail as the first step in degrading mRNA
Registry number: EC 3.1.13.4
Synonym: poly(a) nuclease, mRNA poly(a) nuclease, poly(a) ribonuclease (pan), pan2 protein
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heart-stricken
    ½½ÇÄ¿¡ Á¥¾î ¹ö¸°
  • heart-struck
    ½½ÇÄ¿¡ Á¥¾î ¹ö¸°
  • learn by heart
    ¾Ï±âÇÏ´Ù
  • lose heart
    ³«´ãÇÏ´Ù
  • take heart
    Èñ¸ÁÀ» °®´Ù
  • take to heart
    ÁøÁöÇÏ°Ô ¹Þ¾ÆµéÀÌ´Ù
  • Purple Heart
    ¸í¿¹ »óÀ̱âÀå;(ÇÏÆ®Çü)ÈïºÐÁ¦
  • bleeding heart
    ±Ý³¶È­
  • heart
    ½ÉÀå;°¡½¿(¼Ó);¸¶À½;¸¶À½¼Ó;º»½É;¾ÖÁ¤;¿ë±â;±â·Â;¿ø±â;Áß½É;Áß¾Ó;ÇÙ½É
  • heart attack
    =HEART FAILURE
  • heart cherry
    ¾ÞµÎÀÇ ÀÏÁ¾(½ÉÀå ¸ð¾çÀÇ)
  • heart failure
    ½ÉÀ帶ºñ;½ÉÀå¹ßÀÛ
  • heart murmur
    ½ÉÀå ÀâÀ½
  • heart transplant
    ½ÉÀåÀ̽Ä
  • heart transplat
    ½ÉÀåÀ̽Ä
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á